Glossary · Tax
R&D tax credit and the payroll tax offset
A federal credit that pre-revenue biotechs can use against payroll taxes, worth up to $500,000 a year in cash.
The Section 41 research credit rewards qualified research expenses: wages of people performing or directly supervising research, supplies consumed in it, and a portion of contract research. A clinical-stage biotech typically has large qualifying wages and contract research, so the credit is meaningful. The catch has always been that a company with no income tax owes nothing for a credit to offset.
Since 2016 a qualified small business, meaning one with under $5 million of gross receipts and no gross receipts more than five years back, can elect to apply the credit against the employer share of payroll taxes. The annual cap is $500,000 for tax years beginning after 2022. That turns the credit into cash within the year, which for a startup can equal a month of runway.
The credit requires a study documenting the qualifying activities and costs, is claimed on the timely filed return, and interacts with Section 174. Many states, including Massachusetts, offer their own credits with different rules.
General explanation, not accounting, tax, or legal advice for any specific company. Standards and tax law change; the entry reflects my understanding as of September 2026.